IQVIA Holdings | IQV - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Accenture USD 31.21B 343.17M 2025-12
Agilent USD 6.91B 167M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Cardinal Health USD -2.83B 52M 2026-03
Celltrion KRW 16.7T 182.36B 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cigna USD 41.71B 92M 2025-12
Cognizant Technology Solutions USD 15.07B 53M 2026-03
Computer Programs Systems USD 165.74M 14.62M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
CVS Health USD 75.21B 2.29B 2025-12
Danaher USD 52.95B 415M 2026-03
Dentsply International USD 1.34B 139M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Elevance Health USD 43.9B 124M 2026-03
Humana USD 18.58B 923M 2026-03
IBM USD 32.97B 327M 2026-03
Illumina USD 2.72B 342M 2025-12
Infosys INR 830.26B 809.52B 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
McKesson USD -1.3B 441M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 251.83M 54.32M 2025-12
Publicis EUR 10.45B 816M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Revvity USD 7.38B 180.27M 2025-09
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Tilray USD 1.58B 39.08M 2025-09
UnitedHealth USD 101.7B 4.12B 2025-12
Veeva Systems USD 7.21B 174.12M 2025-12
Veradigm USD 1.02B 159.52M 2022-12
Waters USD 2.56B 230.55M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09